Norway, May 8 -- EXACT Therapeutics AS, a clinical stage precision medicine company utilizing the power of ultrasound to enable targeted drug delivery in oncology, has been informed that the Intellectual Property Office in Japan has granted EXACT its patent no. 7662207 entitled "Treatment of pancreatic cancer".The granted patent covers the treatment of pancreatic cancer using EXACT's proprietary Acoustic Cluster Therapy (ACT(R)).
Published by HT Digital Content Services with permission from Pivotal Sources....